{
  "ticker": "BXN",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959459",
  "id": "02959459",
  "pages": 3,
  "price_sensitive": true,
  "date": "20250618",
  "time": "0839",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250618/pdf/06kvhn9hgq4q1b.pdf",
  "summary": "**Material Information Summary:**  \n\n- **Regulatory Compliance Achieved:** Bioxyne subsidiary Breathe Life Sciences (BLS) received GMP certification under Mutual Recognition Agreements with Australia, Singapore, Euro Zone/EU, Canada, and the UK, facilitating global expansion.  \n- **Strategic Focus:** Expansion into high-growth markets (UK, Germany, EU) emphasized; FY2026 growth outlook highlighted.  \n- **Future Guidance:** FY2026 financial guidance to be provided in August 2025.  \n\n*Omitted:* Operational details, brand descriptions, and non-material corporate background.",
  "usage": {
    "prompt_tokens": 1259,
    "completion_tokens": 120,
    "total_tokens": 1379,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-17T22:55:08.200062"
}